• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Testicular cancer developed in a chronic myeloid leukemia patient with a continued complete cytogenetic and molecular response to imatinib. A case report and review of the literature.

作者信息

Kata Dariusz, Mrówka-Kata Katarzyna, Seweryn Marek, Pajak Jacek, Najda Jacek, Kyrcz-Krzemień Sławomira

出版信息

Leuk Res. 2010 Sep;34(9):e229-31. doi: 10.1016/j.leukres.2010.03.019. Epub 2010 Mar 31.

DOI:10.1016/j.leukres.2010.03.019
PMID:20359744
Abstract
摘要

相似文献

1
Testicular cancer developed in a chronic myeloid leukemia patient with a continued complete cytogenetic and molecular response to imatinib. A case report and review of the literature.
Leuk Res. 2010 Sep;34(9):e229-31. doi: 10.1016/j.leukres.2010.03.019. Epub 2010 Mar 31.
2
Factors predicting molecular and cytogenetic response in chronic myeloid leukemia patients treated with imatinib.预测伊马替尼治疗的慢性髓性白血病患者分子和细胞遗传学反应的因素。
Haematologica. 2005 Jan;90(1):131-3.
3
Isolated blast crisis in CNS in a patient with chronic myelogenous leukemia maintaining major cytogenetic response after imatinib.一名慢性髓性白血病患者在接受伊马替尼治疗后维持主要细胞遗传学反应，却出现了孤立的中枢神经系统原始细胞危象。
J Clin Oncol. 2006 Aug 20;24(24):4028-9. doi: 10.1200/JCO.2006.05.5608.
4
Complete cytogenetic and molecular response after imatinib treatment for chronic myeloid leukemia in a patient with atypical karyotype and BCR-ABL b2a3 transcript.伊马替尼治疗伴有非典型核型和BCR-ABL b2a3转录本的慢性髓性白血病患者后的完全细胞遗传学和分子反应
Cancer Genet Cytogenet. 2007 Apr 15;174(2):111-5. doi: 10.1016/j.cancergencyto.2006.11.021.
5
[Monitoring bcr/abl mRNA levels in imatinib mesylate treated chronic myeloid leukemia patients by real-time quantitative RT-PCR].[采用实时定量逆转录聚合酶链反应监测甲磺酸伊马替尼治疗的慢性髓性白血病患者的bcr/abl mRNA水平]
Zhonghua Xue Ye Xue Za Zhi. 2005 Jan;26(1):1-5.
6
Molecular responses in patients with chronic myelogenous leukemia in chronic phase treated with imatinib mesylate.甲磺酸伊马替尼治疗慢性期慢性粒细胞白血病患者的分子反应
Clin Cancer Res. 2005 May 1;11(9):3425-32. doi: 10.1158/1078-0432.CCR-04-2139.
7
Clonal cytogenetic abnormalities in patients with chronic myeloid leukemia in complete cytogenetic response to imatinib mesylate.对甲磺酸伊马替尼完全细胞遗传学反应的慢性髓性白血病患者的克隆性细胞遗传学异常
Haematologica. 2005 Apr;90(4):556-8.
8
Achieving a major molecular response at the time of a complete cytogenetic response (CCgR) predicts a better duration of CCgR in imatinib-treated chronic myeloid leukemia patients.在接受伊马替尼治疗的慢性髓性白血病患者中，在获得完全细胞遗传学缓解（CCgR）时达到主要分子学缓解预示着CCgR的持续时间更长。
Clin Cancer Res. 2006 May 15;12(10):3037-42. doi: 10.1158/1078-0432.CCR-05-2574.
9
Rituximab associated to imatinib for coexisting therapy-related chronic myeloid leukaemia and relapsed non-Hodgkin lymphoma.利妥昔单抗联合伊马替尼用于同时存在的治疗相关慢性粒细胞白血病和复发性非霍奇金淋巴瘤的联合治疗
Leuk Res. 2008 Feb;32(2):353-5. doi: 10.1016/j.leukres.2007.07.023. Epub 2007 Sep 7.
10
Chronic myeloid leukemia in a patient with acquired immune deficiency syndrome: complete cytogenetic response with imatinib mesylate: report of a case and review of the literature.获得性免疫缺陷综合征患者的慢性髓性白血病：甲磺酸伊马替尼治疗后完全细胞遗传学缓解：一例报告并文献复习
Leuk Res. 2004 Jun;28(6):657-60. doi: 10.1016/j.leukres.2003.10.020.

引用本文的文献

1
Testicular choriocarcinoma: a rare variant that requires a unique treatment approach.睾丸绒毛膜癌：一种需要独特治疗方法的罕见变体。
Curr Oncol Rep. 2015 Feb;17(2):2. doi: 10.1007/s11912-014-0430-0.
2
Occurrence of secondary malignancies in chronic myeloid leukemia during therapy with imatinib mesylate-single institution experience.甲磺酸伊马替尼治疗慢性髓性白血病期间继发恶性肿瘤的发生情况——单机构经验
Mediterr J Hematol Infect Dis. 2015 Jan 1;7(1):e2015003. doi: 10.4084/MJHID.2015.003. eCollection 2015.